Absolute Antibody
17 inventions
Anti-CD3, Recombinant [UCH-T1®]
Invented by Prof Peter Beverley at Absolute Antibody Cancer Research UK London Research Institute: Lincoln's Inn Fields
FACS
IHC
IP
WB
Antigen/Gene or Protein Targets: Protein tyrosine phosphatase, receptor type, C (PTPRC, CD45RO)
0
reviews
1
reference
0
suppliers
FACS
IHC
IF
WB
Antigen/Gene or Protein Targets: Decay accelerating factor (DAF, CD55)
0
reviews
1
reference
0
suppliers
FACS
IHC
IF
IP
WB
Antigen/Gene or Protein Targets: Epidermal Growth Factor Receptor (EGFR, Her1)
0
reviews
1
reference
0
suppliers
IHC
IP
WB
Antigen/Gene or Protein Targets: Human Papilloma Virus-16 and 18 early protein 6 (HPV16E6 & HPV18 E6)
0
reviews
1
reference
0
suppliers
FACS
IHC
IF
IP
WB
Antigen/Gene or Protein Targets: Proliferating cell nuclear antigen, (PCNA), also known as cyclin or polymerase delta accessory protein
0
reviews
1
reference
0
suppliers
Page
1
of
2
1 reagent managed
Anti-MUC1, Recombinant [HMFG2]
Invented by Prof Joy Burchell at Absolute Antibody Cancer Research UK London Research Institute: Lincoln's Inn Fields
![ELISA showing equivalence in performance between anti-MUC1, Recombinant [HMFG2] ("recombinant HMFG2") and Anti-MUC1 [HMFG2] ("purified HMFG2"). ELISA was performed on a 60mer peptide which consists of 3 tandem repeats of MUC1. The secondary anti-mouse antibody was HRP linked and the binding identified with a coloured substrate, O-phenylenediamine. Data kindly provided by Dr. Joy Burchell and Prof. Joyce Taylor-Papadimitriou](https://ximbio.com/img/8950d90e-3d55-4955-9627-396eb9613eb4.jpg)
ELISA
FACS
IHC
IP
WB
Antigen/Gene or Protein Targets: Mucin1 (MUC1)
0
reviews
1
reference
0
suppliers
